Found 41 Aging trials
A listing of Aging medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
To collect Tau PET imaging in cognitively normal older African American (AA) adults in the ABCD2 study to determine relationship to clinical, cognitive, and other biomarker data. Findings from this study will likely provide insight into the mechanisms and distinctions of age-related cognitive decline and that of Alzheimer's disease. Eligible …
Gilteritinib, given with venetoclax and azacitidine, is a potential new treatment for people with acute myeloid leukemia with changed FLT3 gene where chemo is not an option due to old age/other conditions. Aims of this study: find suitable doses of gilteritinib, venetoclax and azacitidine as combined treatment; to learn how …
Adults 65 and older are more likely to have significant injuries from minor things like falls. They can have problems regaining strength due to sarcopenia (loss of muscle tissue as part of natural aging process). Nicotinamide riboside/pterstilbene (Basis) is commercially available nutraceutical. This randomized, double blind placebo controlled trial will …
See protocol section 2 See protocol section 2 See protocol section 3 changed
This a multi-center prospective cohort study of a series of commands surveying responsiveness following laryngoscopy and intubation. Clinical care will not be controlled and will be left to local policy. We will also collect routinely recorded clinical data to frame the observations about IFT responsiveness (please see list below and …
The purpose of this study is to investigate the safety and efficacy of an investigational drug called IPN60130 in the treatment of FOP. IPN60130 is considered “investigational” because it has not been approved by the United States Food and Drug Administration (U.S. FDA) for the treatment of FOP.
This research study is being conducted to learn how well Staccato Alprazolam works and how safe it is for the treatment of epilepsy. Some participants will receive a placebo.
This study will test danicopan, a new drug that is being developed by Alexion to slow down progression of GA. The goals of this study are as follows: • To find out whether danicopan can slow the rate of GA disease progression, and in turn slow the loss of visual …
A study to investigate efficacy and safety of OG-6219 BID in 3 dose levels compared with Placebo in participants aged 18 to 49 with moderate to severe endometriosis-related pain
This research study is being conducted to examine the effects of electronic cigarette aerosol, in the presence and absence of nicotine, on the endothelium, a layer of cells that act as a protective barrier and play an important part in controlling the flow of blood around the body.
Please choose between Voice or SMS based delivery of verification code
or